Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

14 Dec 2017 07:00

RNS Number : 2848Z
PZ CUSSONS PLC
14 December 2017
 

14 December 2017

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2017.

 

Overview

Revenue for the half year to 30 November 2017 was slightly higher than the prior period with performance underpinned by a robust and innovative product pipeline.

 

First half operating profits will be approximately 10% lower than the previous period with strong profitability in Asia offset by reduced margins in some business units in Europe and in particular Africa as a result of the economic environment and competitive trading conditions.

 

Performance in these business units is expected to improve in the second half as a result of new product launches and distribution expansion, together with the usual seasonal uplift in Nigeria. 

 

Brand initiatives planned across the Group for the second half are expected to deliver a full year outturn broadly in line with the prior year.

 

The Group's balance sheet remains strong with the seasonal increase in working capital in Nigeria expected to unwind during the second half.

 

First half trading

 

Europe

 

In the UK, consumers are shopping cautiously reflecting general cost inflation outstripping wage growth, and broader economic uncertainty. This has created tough conditions in the trade in the first half which has adversely affected performance. Further brand initiatives are planned for the second half across Imperial Leather, Carex and, in particular, Original Source.

 

Performance in the Beauty division has been robust across Sanctuary, St Tropez, Charles Worthington and Fudge. The new millennial Sanctuary Being range is now in store in the US and Canada in addition to its UK distribution.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, profitability has improved across all categories of Personal Care, Home Care and Food & Nutrition, continuing the positive momentum of the second half of the prior year.

 

In Indonesia, profitability has also been good with mix improvement across both the core Cussons Baby range as well as from recent new product launches under Imperial Leather and Cussons Kids.

 

Performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, the Naira has been stable against the US dollar on the interbank market and has strengthened slightly on the secondary market as a result of improved dollar liquidity levels. However, Naira credit availability in the trade has been tight during the first half and the environment for consumers remains challenging following the very significant cost inflation of recent years.

 

Performance in Personal Care and Home Care and in the PZ Wilmar joint venture has been robust. Tougher trading conditions have been evident in sales of bulk milk as a result of competitor pricing pressure and in Electricals which is reliant on discretionary spend affordability, with profitability in these business units significantly impacted in the first half. A number of initiatives across the Nigeria business, including distribution expansion and new product launches, are planned for the remainder of the year to improve performance as the business enters peak season.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Full year outlook

 

The strength of the Group's brand portfolio and innovation pipeline continues to ensure that the market shares of our products remain strong in all markets.

 

Whilst tough trading conditions are expected to continue for the full year with the consumer under pressure in all markets, brand initiatives planned for the second half are expected to deliver a full year outturn broadly in line with the prior year.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Interim Announcement

 

Interim results for the half year to 30 November 2017 will be announced on Tuesday 30 January 2018.

 

Notes

 

1. Financial results for the Nigeria listed entity will be released in Nigeria today in accordance with local market requirements and in line with the commentary provided above.

 

- ENDS -

 

For further information contact:

 

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

 

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGCCPUPMGQW
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.